Collectively, in this study, we aimed to explore the mechanism of the SULF2-mediated ERK/AKT signaling pathway in cervical cancer to provide theoretical evidence and an experimental foundation for the development of clinical treatments for cervical cancer. The gene discussed is AKT1; the disease is cervical carcinoma.